Cancer Risk from Medical Radiation Procedures for Coronary Artery Disease: A Nationwide Population-based Cohort Study

  • Hung, Mao-Chin (Department of Medical Imaging and Radiological Sciences, Tzu Chi College of Technology) ;
  • Hwang, Jeng-Jong (Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University)
  • Published : 2013.05.30


To assess the risk of cancer incidence after medical radiation exposure for coronary artery disease (CAD), a retrospective cohort study was conducted based on Taiwan's National Health Insurance Research Database (NHIRD). Patients with CAD were identified according to the International Classification of Diseases code, 9th Revision, Clinical Modification (ICD-9-CM), and their records of medical radiation procedures were collected from 1997 to 2010. A total of 18,697 subjects with radiation exposure from cardiac imaging or therapeutic procedures for CAD were enrolled, and 19,109 subjects receiving cardiac diagnostic procedures without radiation were adopted as the control group. The distributions of age and gender were similar between the two populations. Cancer risks were evaluated by age-adjusted incidence rate ratio (aIRR) and association with cumulative exposure were further evaluated with relative risks by Poisson regression analysis. A total of 954 and 885 subjects with various types of cancers in both cohorts after following up for over 10 years were found, with incidences of 409.8 and 388.0 per 100,000 person-years, respectively. The risk of breast cancer (aIRR=1.85, 95% confidence interval: 1.14-3.00) was significantly elevated in the exposed female subjects, but no significant cancer risk was found in the exposed males. In addition, cancer risks of the breast and lung were increased with the exposure level. The study suggests that radiation exposure from cardiac imaging or therapeutic procedures for CAD may be associated with the increased risk of breast and lung cancers in CAD patients.


Coronary artery disease (CAD);cardiac imaging;cancer risk;incidence rate ratio (IRR)


  1. Brenner DJ, Doll R, Goodhead DT, et al (2003). Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA, 100, 13761-6.
  2. Cardis E, Kesminiene A, Ivanov V, et al (2005a). Risk of thyroid cancer after exposure to 131I in childhood. JNCI, 97, 724-32.
  3. Cardis E, Vrijheid M, Blettner M, et al (2005b). Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ, 331, 77.
  4. Chen TR, Tyan YS, Teng PS, et al (2011). Population dose from medical exposure in Taiwan for 2008, Med Phys, 38, 3139-48.
  5. Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ (2007a). Radiation dose to patients from cardiac diagnostic imaging. Circulation, 116, 1290-305.
  6. Einstein AJ, Henzlova MJ, Rajagopalan S (2007b). Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA, 298, 317-23.
  7. Hwang SL, Guo HR, Hsieh WA, et al (2006). Cancer risks in a population with prolonged low dose-rate gamma-radiation exposure in radiocontaminated buildings, 1983 - 2002. Int J Radiat Biol, 82, 849-58.
  8. International Commission on Radiological Protection (2007). The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103, Elsevier, New York, Ann ICRP 37(2-4).
  9. Lucas FL, DeLorenzo MA, Siewers AE, Wennberg DE (2006). Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001. Circulation, 113, 374-9.
  10. Ma H, Hill CK, Bernstein L, Ursin G (2008). Low-dose medical radiation exposure and breast cancer risk in women under age 50 years overall and by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res Treat, 109, 77-90.
  11. Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M (2008). Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology, 248, 254-63.
  12. Mullenders L, Atkinson M, Paretzke H, Sabatier L, Bouffler S (2009). Assessing cancer risks of low-dose radiation. Nat Rev Cancer, 9, 596-604.
  13. Ozasa K, Shimizu Y, Suyama A, et al (2012). Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat Res, 177, 229-43.
  14. Pierce DA, Preston DL (2000). Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res, 154, 178-86.[0178:RRCRAL]2.0.CO;2
  15. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K (2003). Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res, 160, 381-407.
  16. Romanenko A, Bebeshko V, Hatch M, et al (2008). The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: I. Study methods. Radiat Res, 170, 691-7.
  17. Schonfeld SJ, Bhatti P, Brown EE, et al (2010). Polymorphisms in oxidative stress and inflammation pathway genes, lowdose ionizing radiation, and the risk of breast cancer among US radiologic technologists. Cancer Causes Control, 21, 1857-66.

Cited by

  1. Correcting Systemic Deficiencies in our Scientific Infrastructure vol.12, pp.2, 2014,
  2. Risk of cancer among cardiologists who frequently perform percutaneous coronary interventions: a population-based study vol.46, pp.6, 2016,